NCT03462069 - Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

April 18, 2019

Study Completion Date

April 18, 2019

Conditions

Diabetes Mellitus

Interventions

DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: tablet~Route of administration: oral"

DRUG

Placebo

"Pharmaceutical form: tablet~Route of administration: oral"

DRUG

Empagliflozin

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

Placebo

"Pharmaceutical form: capsule~Route of administration: oral"

Trial Locations (1)

Investigational Site Number 2760001, Berlin